Elutia (ELUT) Cash from Financing Activities (2019 - 2026)
Elutia's (ELUT) quarterly Cash from Financing Activities came in at $3000.0 in Q1 2026, down 99.98% year-on-year from $13.3 million in Q1 2025, and up 100.01% quarter-over-quarter from -$23.1 million in Q4 2025.
Elutia (ELUT) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Elutia has disclosed Cash from Financing Activities across 8 years of filings, most recently posting $3000.0 for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $3000.0, down 99.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.9 million (down 169.43% YoY), and the FY2025 annual result was -$10.6 million, down 162.23% from the prior year.
- Cash from Financing Activities came in at $3000.0 for Q1 2026 at Elutia, up from -$23.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $14.3 million in Q4 2022 to a low of -$23.1 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is -$151000.0 (2024), against an average of $1.4 million.
- Across the five-year window, Cash from Financing Activities jumped 51610.53% in 2024 and sank 15223.18% in 2025, its largest moves.
- Elutia's Cash from Financing Activities stood at $14.3 million in 2022, then slumped by 104.87% to -$695000.0 in 2023, then surged by 78.27% to -$151000.0 in 2024, then tumbled by 15223.18% to -$23.1 million in 2025, then jumped by 100.01% to $3000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $3000.0 (Q1 2026), -$23.1 million (Q4 2025), and -$262000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Elutia | 45.15 Mn | 16.66 Mn | 1.80 Mn | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | -23.14 Mn |
| Dec 31, 2025 | -23.14 Mn |
| Sep 30, 2025 | -262,000.00 |
| Sep 30, 2025 | -262,000.00 |
| Jun 30, 2025 | -516,000.00 |
| Jun 30, 2025 | -516,000.00 |
| Mar 31, 2025 | 13.28 Mn |
| Mar 31, 2025 | 13.28 Mn |
| Dec 31, 2024 | -151,000.00 |
| Dec 31, 2024 | -151,000.00 |
| Sep 30, 2024 | 11.53 Mn |
| Sep 30, 2024 | 11.53 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | -4.07 Mn |
| Mar 31, 2024 | -4.07 Mn |
| Dec 31, 2023 | -695,000.00 |
| Dec 31, 2023 | -695,000.00 |